Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
May 23, 2019
Despite their intended use for rare diseases, so-called orphan drugs contribute substantially to prescription drug spending; in fact, it is estimated that in just two years’ time, orphan drugs will constitute more than 20 percent of the market for global pharmaceutical sales. Nowhere is t...
Blog Post
May 16, 2019
The next pandemic is coming. We don’t know when it will hit or what it will be, but we do know that risk factors for the spread of infectious disease are worsening. The 2014–15 Ebola outbreak in West Africa provides a useful microcosm of the challenges a pandemic would pose. My new ...
Blog Post
March 19, 2019
PEPFAR has long enjoyed bipartisan support on the Hill. Yet, it has not been spared from significant cuts in President Trump’s latest budget request for foreign aid. It is noteworthy that this administration’s three successive budget requests have proposed increasingly large cu...